Investing.com - MorphoSys ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
MorphoSys ADR announced earnings per share of €-0.9503 on revenue of €44.94M. Analysts polled by Investing.com anticipated EPS of €-0.8326 on revenue of €46.29M.
MorphoSys ADR shares are down 61.12% from the beginning of the year, still down 64.16% from its 52 week high of €30.75 set on January 26. They are under-performing the Nasdaq which is up 21.22% from the start of the year.
MorphoSys ADR follows other major Healthcare sector earnings this month
MorphoSys ADR's report follows an earnings beat by J&J on October 19, who reported EPS of €2.6 on revenue of €23.34B, compared to forecasts EPS of €2.35 on revenue of €23.64B.
Pfizer had beat expectations on November 2 with third quarter EPS of €1.34 on revenue of €24.09B, compared to forecast for EPS of €1.08 on revenue of €22.58B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar